You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2024

NATAMYCIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for natamycin and what is the scope of patent protection?

Natamycin is the generic ingredient in one branded drug marketed by Harrow Eye and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for natamycin. Two suppliers are listed for this compound.

Summary for NATAMYCIN
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 35
Clinical Trials: 7
What excipients (inactive ingredients) are in NATAMYCIN?NATAMYCIN excipients list
DailyMed Link:NATAMYCIN at DailyMed
Recent Clinical Trials for NATAMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Aravind Eye Care SystemPhase 3
Thomas M. LietmanPhase 3
Stanford UniversityPhase 3

See all NATAMYCIN clinical trials

Pharmacology for NATAMYCIN
Medical Subject Heading (MeSH) Categories for NATAMYCIN

US Patents and Regulatory Information for NATAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Harrow Eye NATACYN natamycin SUSPENSION;OPHTHALMIC 050514-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

NATAMYCIN Market Analysis and Financial Projection

Natamycin Market Dynamics and Financial Trajectory

Introduction to Natamycin

Natamycin, a natural antifungal agent extracted from Streptomyces natalensis, has been increasingly pivotal in various industries, including food preservation, pharmaceuticals, and animal feed. Its efficacy in suppressing fungal growth without affecting the taste or texture of products has made it a favored choice across multiple sectors.

Market Size and Growth Projections

The global natamycin market is anticipated to experience significant growth over the coming years. Here are some key projections:

  • Market Size in 2023: The market was valued at approximately USD 186 million in 2023[2].
  • Projected Market Size by 2030: It is expected to reach USD 288.6 million by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 6.4% from 2023 to 2030[2].
  • Alternative Projections: Other reports suggest the market could reach USD 250 million by 2031, growing at a CAGR of 1% from 2024 to 2031[3], or USD 91.75 million by 2031, with a CAGR of 3.30% from 2024 to 2031[4].

Driving Factors

Several factors are driving the growth of the natamycin market:

Increasing Demand for Natural Preservatives

The rising consumer preference for clean-label and natural products is a significant driver. Consumers are increasingly seeking food products with fewer artificial additives, making natamycin a popular choice for food preservation[2][4].

Expansion of the Food Processing Industry

The global food processing industry is expanding, and the need for effective preservatives to enhance shelf life is growing. Natamycin's ability to prevent fungal growth in products like cheese, meat, and bakery items makes it an essential component in this sector[2].

Pharmaceutical Applications

Natamycin is also used in the pharmaceutical industry, particularly for treating ophthalmic disorders. Its antifungal properties make it a valuable asset in medical treatments, contributing to market growth[2].

Regulatory Standards

High food hygiene and safety standards enforced by regulatory authorities worldwide are driving the demand for natamycin. Its use helps extend the shelf life of various food products, aligning with these stringent regulations[4].

Regional Insights

North America

North America leads the natamycin market due to its strong food processing industry and high standards for food safety. The region's preference for natural and clean-label ingredients further fuels the demand for natamycin[2].

Other Regions

Other significant regions include Europe, Asia-Pacific, Latin America, and the Middle East & Africa. These regions are also experiencing growth, driven by increasing food production and consumer demand for safe and natural food products[3].

Impact of COVID-19

The COVID-19 pandemic had a significant impact on the natamycin market, primarily due to supply chain disruptions and production limitations. Movement restrictions and lockdowns affected manufacturing and supply chain processes, leading to lower-than-anticipated demand across all regions. However, as markets return to pre-pandemic levels, the demand for natamycin is rebounding[2].

Regulatory Restrictions

Regulatory restrictions pose a challenge to the natamycin market. Strict measures on the maximum allowed concentration of natamycin in food products vary by country, which can hinder market expansion and create challenges for suppliers and manufacturers[2].

Key Industry Players

Major players in the natamycin market are driving growth through innovation and expansion strategies. These companies invest in research projects to improve the effectiveness of natamycin and discover new applications, thereby enhancing customer trust and expanding the product's range of uses[2].

Latest Trends

Growing Use in Pharmaceuticals and Animal Feed

Natamycin's antifungal qualities are increasingly being utilized in the pharmaceutical and animal feed sectors. This broader application is contributing to the market's growth trajectory[4].

Consumer Preference for Clean-Label Products

The trend towards clean-label products continues to drive the demand for natamycin. Consumers' growing awareness of food safety and their preference for natural ingredients are key factors in this trend[4].

"Natamycin’s rising application breadth in the pharmaceutical and animal feed sectors, owing to its antifungal qualities, drives market expansion."[4]

Financial Trajectory

The financial trajectory of the natamycin market is characterized by steady growth driven by increasing demand and expanding applications.

  • Revenue Growth: The market is expected to grow from USD 186 million in 2023 to USD 288.6 million by 2030, with a CAGR of 6.4%[2].
  • Investment in Innovation: Key industry players are investing in research and development to enhance the effectiveness and applications of natamycin, further driving market growth[2].

Conclusion

The natamycin market is poised for significant growth, driven by increasing demand for natural preservatives, expansion of the food processing industry, and growing applications in pharmaceuticals and animal feed. Despite regulatory challenges and the impact of the COVID-19 pandemic, the market is expected to continue its upward trajectory.

Key Takeaways

  • The global natamycin market is projected to reach USD 288.6 million by 2030, with a CAGR of 6.4% from 2023 to 2030.
  • Increasing consumer preference for natural preservatives and the expansion of the food processing industry are key drivers.
  • Regulatory standards and growing applications in pharmaceuticals and animal feed also contribute to market growth.
  • North America leads the market due to its strong food processing industry and high food safety standards.
  • The COVID-19 pandemic had a temporary impact on the market, but demand is rebounding as markets return to pre-pandemic levels.

FAQs

1. What is the expected market size of the natamycin market by 2030? The natamycin market is expected to reach USD 288.6 million by 2030[2].

2. What is the CAGR of the natamycin market from 2023 to 2030? The natamycin market is expected to exhibit a CAGR of 6.4% from 2023 to 2030[2].

3. What are the primary drivers of the natamycin market? The primary drivers include increasing consumer preference for natural preservatives, expansion of the food processing industry, and growing applications in pharmaceuticals and animal feed[2][4].

4. How did the COVID-19 pandemic impact the natamycin market? The COVID-19 pandemic caused supply chain disruptions and lower demand due to production limitations and movement restrictions. However, demand is rebounding as markets return to pre-pandemic levels[2].

5. Which region leads the natamycin market? North America leads the natamycin market due to its strong food processing industry and high standards for food safety[2].

Sources

  1. Polaris Market Research - Natamycin Market Size Worth $94.28 Million By 2032 | CAGR: 3.4% https://www.polarismarketresearch.com/press-releases/natamycin-market
  2. Business Research Insights - Natamycin Market Size, Share, Trend, Growth Report 2024-2032 https://www.businessresearchinsights.com/market-reports/natamycin-market-114626
  3. Market Research Intellect - Natamycin Market Size and Projections - Market Research Intellect https://www.marketresearchintellect.com/product/global-natamycin-market-size-and-forecast/
  4. Verified Market Research - In-Depth Industry Outlook: Natamycin Market Size & Forecast https://www.verifiedmarketresearch.com/product/natamycin-market/
  5. Market Research - Natamycin Market Size, Trends, Analysis, and Outlook By ... https://www.marketresearch.com/VPA-Research-v4245/Natamycin-Size-Trends-Outlook-Application-38560273/

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.